A Pierringer settlement is when a plaintiff in a civil lawsuit involving multiple defendants agrees to accept a settlement sum from one or more (but not all) defendants. In exchange, the plaintiff agrees to discontinue their claims against those paying defendants. These defendants would no longer participate in the proceeding (as opposed to a Mary Carter Agreement, in which case the defendants would continue to participate in the proceeding).
The plaintiff assumes all of the financial risks in making such an arrangement. If they underestimate the eventual liability share of the settling defendants, they cannot make up any shortfall from the remaining defendants. Conversely, if the plaintiff eventually recovers a windfall from the settlement (settles for more than is found to be the actual share of liability of the non-settling defendants), they are not entitled to keep the surplus. The court will order that the surplus be used to reduce the amount the non-settling defendants have to pay to satisfy the judgment.
By way of example, assume that there is a claim with damages totalling $1,000,000.00. The suit is against a hospital (with its nurses) and the physicians. The physicians and the hospital are separately represented and have cross-claimed against each other. These two parties at the defence table are outwardly presenting a common front but have left open their right to attack one another during cross-examination. At trial, the trier of fact would establish the respective degrees of fault, if any.
If the hospital and nurses reach a settlement with the plaintiff, say for $400,000.00, the claim against them would be dismissed. The trial against the physicians would now proceed but in the absence of the hospital and its nurses. If the trier of fact determined that the physicians were not liable, that would be the end of the matter. If however it was found that any of the doctors were liable, the trier of fact would then have to determine if the hospital (and nurses) were at fault as well and if so, what were the respective degrees of fault? This would determine how the damages will be apportioned between the parties.
The scenarios above highlight the risks a plaintiff takes when entering into a Pierringer settlement. They do have the comfort of knowing they have received a certain amount of money, but also have to understand and accept that they can never receive more than the total assessed damages. This is so despite taking the risk of receiving less if they are not substantially successful against the non-settling defendants. ONce a settlement is reached, the plaintiffs must then focus their efforts on establishing the liability of the remaining defendants in order to make up the remainder of the damages.
The non-settling defendant(s) are now on their own. Their goal is to implicate the hospital as being the major player in causing the plaintiff’s damages. That will be a somewhat awkward task as the hospital is no longer a party and will be absent from the courtroom unless they or the plaintiffs call the nurses to testify. The plaintiff is unlikely to do so, forcing the non-settling defendants to call them. Calling them in chief to have their evidence before the court means they would normally lose their right of cross-examination.
This very dilemma was faced by the doctors (non-settling defendants) in a recent Ontario Superior Court of Justice decision on the eve of trial. Those defendants sought the right to cross-examine the hospital’s witnesses. They relied on their cross-claim, the dynamics mentioned above and the principles of natural justice.
The court recognized that partial settlements can create both substantial and procedural difficulties. A variety of solutions have been used by the courts in Ontario but the solution that worked here was to allow the non-settling defendants, and the plaintiff, the right to cross-examine any hospital witness no matter which party called them.
At Wise Health Law, our health law lawyers rely on their significant trial and civil litigation experience to provide our clients with exceptional guidance and representation in medical malpractice claims. To find out more about how we can help, contact us online, or at 416-915-4234to schedule a consultation.
The Chief Medical Officer of Health for Ontario has issued an updated Directive #2 (dated May 26, 2020) for Regulated Health Professionals in the province.
Pursuant to the updated Directive #2, all deferred non-essential and elective services by health care providers may be gradually restarted – subject to the rest of the requirements set out in the Directive.
The updated Directive #2 does not provide particularly detailed guidance to health professionals on how to proceed, likely because it applies to such a broad spectrum of health care and health professionals. It does, however, provide some principles to assist health care providers in making decisions as we enter this transitional period.
In addition to the mask and hand sanitizer shortages, Ontario’s response to COVID-19 highlights the need for more frontline health care workers. Each regulated health profession’s college responded differently, and we have discussed some of those changes in other posts to keep you apprised.
Today, we focus on the College of Physicians and Surgeons of Ontario (CPSO), who set out to increase the number of available and licenced physicians out on the frontlines through certificates of registration that authorize supervised practice of short duration. The temporary licences authorize practice for 30 days.
Undoubtedly, COVID-19 has affected how health professionals practice. Pharmacists across the country are not only experiencing changes in how they practice (for example, accepting emailed prescriptions, where appropriate) but the scope of their practice as well. The latter change is not permanent, although the disruptions in practice may be felt long after the COVID-19 emergency subsides.
On March 19, 2020, Health Canada issued a short-term section 56(1) exemption under the Controlled Drugs and Substances Act (CDSA) that would authorize pharmacists to prescribe, sell, or provide controlled substances in limited circumstances, or transfer prescriptions for controlled substances (the CDSA Exemption).